Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

BACKGROUND: There is no standard therapeutic procedure for the hepatocellular carcinoma (HCC) in patients with poor hepatic reserve function. With the approval of newly developed chemotherapeutic agent of miriplatin, we have firstly conducted the phase I study of CDDP powder (DDP-H) and miriplatin c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kamimura, Kenya, Suda, Takeshi, Tamura, Yasushi, Takamura, Masaaki, Yokoo, Takeshi, Igarashi, Masato, Kawai, Hirokazu, Yamagiwa, Satoshi, Nomoto, Minoru, Aoyagi, Yutaka
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2012
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3482551/
https://ncbi.nlm.nih.gov/pubmed/22994941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-12-127
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk